In a population-based, cross-sectional study, researchers examined US women aged 20 to 49 years who were diagnosed with primary invasive breast cancer from 2000 through 2019.
Researchers developed a retrospective cohort study to examine the reoperation rates and health care costs associated with reoperation for patients who underwent breast-conserving surgery.
Using data from observational and clinical trials, researchers examined the association between advancements in metastatic breast cancer treatment and the observed improvement in breast cancer mortality...
Researchers conducted a retrospective analysis of 469 patients with HR+/HER2- metastatic breast cancer and cardiovascular diseases treated with palbociclib plus aromatase inhibitors or aromatase inhibitors...
In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.
In a recent study, researchers sought to determine the potential for the overdiagnosis of breast cancer after screening for women 70 years of age and older.
The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.
Researchers aimed to longitudinally examine both the variability of musculoskeletal pain among individuals with breast cancer and any potential predictors for pain during the first 18 months of aromatase...
Women with breast cancer who are receiving dose-dense paclitaxel are more likely to experience paclitaxel-induced peripheral neuropathy (PIPN) when compared with women who receive the treatment weekly,...
